توقعات سوق الكواشف والمعدات في منطقة آسيا والمحيط الهادئ حتى عام 2030 - التحليل الإقليمي - حسب المنتج (الكواشف والأدوات)، والطريقة (الطرق الفيروسية، والطرق غير الفيروسية، والطرق الهجينة)، والتطبيق (الأبحاث الطبية الحيوية، وإنتاج البروتين، والتوصيل العلاجي)، و المستخدم النهائي (الأكاديميون ومعاهد البحوث وشركات الأدوية والتكنولوجيا الحيوية)
يعزز العبء الاقتصادي المتزايد للسرطان سوق كواشف ومعدات ترنسفكأيشن في آسيا والمحيط الهادئ
وفقًا لمنظمة الصحة العالمية (WHO) يعد السرطان أحد الأسباب الرئيسية للوفاة في جميع أنحاء العالم، وقد تسبب في وفاة ما يقرب من 10 ملايين شخص في عام 2020. وفقًا للوكالة الدولية لأبحاث السرطان، من المرجح أن يزداد عبء السرطان العالمي مع إضافة 30.2 مليون حالة أخرى بحلول عام 2020. 2040. وفقا لمنظمة سرطان الثدي، ما يقرب من 5-10٪ من حالات سرطان الثدي في جميع أنحاء العالم هي وراثية وتسببها جينات غير طبيعية تنتقل من الأجيال. وبحسب مقال \"نمط الحياة والمخاطر الجينية وحدوث السرطان\" المنشور في المجلة الدولية لعلم الأوبئة عام 2023، فإن ما يقرب من 33% من حالات السرطان التي تحدث هي وراثية، كما أن خطر الطفرات الجينية مرتفع في المرض. ومن ثم، يختار الناس التنميط الجيني للكشف المبكر والعلاج الشخصي لحالات السرطان الوراثية. يُشار أحيانًا إلى BRCA1 وBRCA2 بالجينات الكابتة للورم. الأشخاص الذين يرثون المتغيرات الضارة لأحد هذه الجينات يكونون أكثر عرضة لخطر الإصابة بالعديد من أنواع السرطان، وأبرزها سرطان الثدي والمبيض، من بين أنواع أخرى. يميل هؤلاء الأشخاص أيضًا إلى الإصابة بالسرطان في سن أصغر مقارنةً بالأشخاص الذين ليس لديهم اختلافات في الجينات المذكورة. من المرجح أن تساعد الدراسات التي تركز على معالجة الحمض النووي بواسطة الخلايا السرطانية في فهم عملية التمثيل الغذائي للسرطان. عادة ما يتم تعبئة الحمض النووي في جسيم فيروسي أو غير فيروسي ليتم نقله إلى الخلية التي سيتم نقلها. تم اقتراح نقل الجينات كنهج جديد لتعزيز فعالية الأدوية المضادة للأورام في علاج السرطانات المستعصية أو النقيلية. تم الإبلاغ عن أن الارتباط بين العلاج الجيني والأدوية (العلاج المشابه) يعزز التأثيرات المضادة للتكاثر للعلاجات الكلاسيكية في سرطانات الرئة والقولون والمستقيم والبنكرياس والمثانة والثدي وغيرها. وبالتالي، فإن العبء الاقتصادي المتزايد للسرطان يعزز سوق كواشف ومعدات ترنسفكأيشن في آسيا والمحيط الهادئ. نظرة عامة على كواشف ومعدات ترنسفكأيشن في آسيا والمحيط الهادئ
تصنف منطقة آسيا والمحيط الهادئ إلى الصين واليابان والهند وكوريا الجنوبية وأستراليا وبقية دول آسيا والمحيط الهادئ. تمتلك الصين أكبر حصة سوقية في عام 2022. تتمتع دول آسيا والمحيط الهادئ مثل الصين والهند وسنغافورة وغيرها بنظام رعاية صحية راسخ بالإضافة إلى صناعات دوائية وطبية سريعة النمو. يوجد في هذه البلدان العديد من مرافق الرعاية الصحية التي تقدم خدمات العلاج والرعاية لمرضى السرطان. ووفقا لدراسة أجرتها المعاهد الوطنية للصحة، ارتفع عدد حالات قبول المرضى سنويا في مستشفيات السرطان في الصين من 1.10 مليون إلى 3.24 مليون خلال الفترة 2010-2020. وفقًا لدراسة نشرت عام 2023 في مجلة الجمعية الطبية الأمريكية، تم تسجيل معدل انتشار مرض الكلى المزمن (CKD) لدى الأشخاص الذين تبلغ أعمارهم 18 عامًا أو أكثر في البر الرئيسي للصين بنسبة 8.2٪. علاوة على ذلك، تشير أحدث البيانات الصادرة عن الوكالة الدولية لأبحاث السرطان (IARC) إلى أن المعدل الموحد للعمر المقدر لسرطان المعدة في الصين يبلغ 21 لكل 100 ألف، والمعدل الخام 33.06؛ بالنسبة لسرطان البنكرياس، يبلغ معدل ASR 5 لكل 100000 بمعدل خام 8.6. وبحسب المصدر نفسه، فإن العدد التقديري لحالات سرطان المعدة وسرطان البنكرياس الجديدة لدى الأشخاص الذين تتراوح أعمارهم بين 0 و 74 عاما في عام 2020 (لكلا الجنسين) بلغ 478508 و 124994 على التوالي. وبالتالي، فإن العبء المرتفع للأمراض المزمنة يدفع الطلب على CGTs في الصين، مما يؤدي بدوره إلى تغذية كواشف ترنسفكأيشن ونمو سوق المعدات.
إيرادات سوق كواشف ومعدات ترنسفكأيشن في آسيا والمحيط الهادئ وتوقعاتها حتى عام 2030 (مليون دولار أمريكي)
تجزئة سوق كواشف ومعدات ترنسفكأيشن في آسيا والمحيط الهادئ
كواشف ومعدات ترنسفكأيشن في آسيا والمحيط الهادئ يتم تقسيم السوق بناءً على المنتج والطريقة والتطبيق والمستخدم النهائي والبلد.
استنادًا إلى المنتج، ينقسم سوق كواشف ومعدات ترنسفكأيشن في آسيا والمحيط الهادئ إلى كواشف وأدوات. استحوذ قطاع الكواشف على حصة أكبر في عام 2022.
من حيث الطريقة، يتم تقسيم سوق كواشف ومعدات ترنسفكأيشن في آسيا والمحيط الهادئ إلى طرق فيروسية، وطرق غير فيروسية، وطرق هجينة. استحوذ قطاع الأساليب غير الفيروسية على الحصة الأكبر في عام 2022. وينقسم القطاع الفيروسي إلى فيروسات قهقرية وفيروسات غدية وفيروسات غدية مرتبطة وفيروس الهربس. وينقسم الجزء غير الفيروسي إلى طريقة فيزيائية/ميكانيكية وطريقة كيميائية. علاوة على ذلك، يتم تصنيف جزء الطريقة الفيزيائية/الميكانيكية إلى Electroporation لل، والحقن المجهري، والطريقة البيولوجية، وطريقة الليزر، وmagnetofection، وsonoporation. أيضًا، يتم تصنيف جزء الطريقة الكيميائية إلى قسمين: أساسه دهني/عالي الدهون، وغير دهني/عالي الدهون. من خلال التطبيق، يتم تقسيم سوق كواشف ومعدات ترنسفكأيشن في آسيا والمحيط الهادئ إلى أبحاث الطب الحيوي، وإنتاج البروتين، وتقديم العلاج. استحوذ قطاع الأبحاث الطبية الحيوية على الحصة الأكبر في عام 2022. بناءً على المستخدم النهائي، ينقسم سوق كواشف ومعدات ترنسفكأيشن في آسيا والمحيط الهادئ إلى أكاديميين ومعاهد بحثية وشركات الأدوية والتكنولوجيا الحيوية. استحوذ قطاع الأكاديميين ومعاهد البحوث على حصة أكبر في عام 2022.
استنادًا إلى البلد، يتم تصنيف سوق كواشف ومعدات ترنسفكأيشن في آسيا والمحيط الهادئ إلى أستراليا والصين والهند واليابان وكوريا الجنوبية وبقية آسيا. المحيط الهادئ. سيطرت الصين على سوق كواشف ومعدات ترنسفكأيشن في منطقة آسيا والمحيط الهادئ في عام 2022.
Fisher Scientific Inc، وPromega Corp، وF. Hoffmann-La Roche Ltd، وBio-Rad Laboratories Inc، وMirus Bio LLC، وQIAGEN NV، وMerck KGaA، تعد Lonza Group AG وMaxCyte Inc وPolyplus-Transfection SA من الشركات الرائدة العاملة في سوق كواشف ومعدات ترنسفكأيشن في منطقة آسيا والمحيط الهادئ.
TABLE OF CONTENTS
1. Introduction
1.1 The Insight Partners Research Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Insights
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Asia Pacific Transfection Reagents and Equipment Market - Key Market Dynamics
4.1 Asia Pacific Transfection Reagents and Equipment Market - Key Market Dynamics
4.2 Market Drivers
4.2.1 Increasing Popularity of Cell and Gene Therapy
4.2.2 Growing Economic Burden of Cancer
4.3 Market Restraints
4.3.1 High Cost of Instruments and Consumables
4.4 Market Opportunities
4.4.1 Ramping Up Small-Scale Processes to Large-Scale Processes
4.5 Future Trends
4.5.1 Strategic Initiatives by Companies
4.6 Impact of Drivers and Restraints:
5. Transfection Reagents and Equipment Market - Asia Pacific Market Analysis
5.1 Asia Pacific Transfection Reagents and Equipment Market Revenue (US$ Million), 2022-2030
5.2 Asia Pacific Transfection Reagents and Equipment Market Forecast Analysis
6. Asia Pacific Transfection Reagents and Equipment Market Analysis - by Product
6.1 Reagents
6.1.1 Overview
6.1.2 Reagents: Asia Pacific Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
6.2 Equipment
6.2.1 Overview
6.2.2 Equipment: Asia Pacific Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
7. Asia Pacific Transfection Reagents and Equipment Market Analysis - by Modality
7.1 Viral
7.1.1 Overview
7.1.2 Viral: Asia Pacific Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
7.1.2.1 Retrovirus: Asia Pacific Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
7.1.2.2 Adenovirus: Asia Pacific Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
7.1.2.3 Adeno-Associated Virus: Asia Pacific Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
7.1.2.4 Herpes Virus: Asia Pacific Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
7.2 Non-Viral
7.2.1 Overview
7.2.2 Non-Viral: Asia Pacific Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
7.2.2.1 Physical/Mechanical Method: Asia Pacific Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
7.2.2.1.1 Electroporation: Asia Pacific Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
7.2.2.1.2 Microinjection: Asia Pacific Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
7.2.2.1.3 Biolistic Method: Asia Pacific Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
7.2.2.1.4 Laser Method: Asia Pacific Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
7.2.2.1.5 Magnetofection: Asia Pacific Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
7.2.2.1.6 Sonoporation: Asia Pacific Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
7.2.2.2 Chemical Method: Asia Pacific Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
7.2.2.2.1 Liposomal Based/High Lipid: Asia Pacific Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
7.2.2.2.2 Non-Liposomal Based/High Lipid: Asia Pacific Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
7.3 Hybrid
7.3.1 Overview
7.3.2 Hybrid: Asia Pacific Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
8. Asia Pacific Transfection Reagents and Equipment Market Analysis - by Application
8.1 Biomedical Research
8.1.1 Overview
8.1.2 Biomedical Research: Asia Pacific Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
8.2 Protein Production
8.2.1 Overview
8.2.2 Protein Production: Asia Pacific Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
8.3 Therapeutic Delivery
8.3.1 Overview
8.3.2 Therapeutic Delivery: Asia Pacific Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
9. Asia Pacific Transfection Reagents and Equipment Market Analysis - by End Users
9.1 Academic and Research Institutes
9.1.1 Overview
9.1.2 Academic and Research Institutes: Asia Pacific Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
9.2 Pharmaceutical and Biotechnological Companies
9.2.1 Overview
9.2.2 Pharmaceutical and Biotechnological Companies: Asia Pacific Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
10. Asia Pacific Transfection Reagents and Equipment Market -Country Analysis
10.1 Asia Pacific: Transfection Reagents and Equipment Market - Revenue and Forecast Analysis - by Country
10.1.1 Asia Pacific: Transfection Reagents and Equipment Market - Revenue and Forecast Analysis - by Country
10.1.1.1 China: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
10.1.1.1.1 China: Transfection Reagents and Equipment Market Breakdown, by Product
10.1.1.1.2 China: Transfection Reagents and Equipment Market Breakdown, by Modality
10.1.1.1.2.1 China: Transfection Reagents and Equipment Market Breakdown, by Viral
10.1.1.1.2.2 China: Transfection Reagents and Equipment Market Breakdown, by Non-Viral
10.1.1.1.2.2.1 China: Transfection Reagents and Equipment Market Breakdown, by Physical/mechanical Method
10.1.1.1.2.2.2 China: Transfection Reagents and Equipment Market Breakdown, by Chemical Method
10.1.1.1.3 China: Transfection Reagents and Equipment Market Breakdown, by Application
10.1.1.1.4 China: Transfection Reagents and Equipment Market Breakdown, by End Users
10.1.1.2 Japan: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
10.1.1.2.1 Japan: Transfection Reagents and Equipment Market Breakdown, by Product
10.1.1.2.2 Japan: Transfection Reagents and Equipment Market Breakdown, by Modality
10.1.1.2.2.1 Japan: Transfection Reagents and Equipment Market Breakdown, by Viral
10.1.1.2.2.2 Japan: Transfection Reagents and Equipment Market Breakdown, by Non-Viral
10.1.1.2.2.2.1 Japan: Transfection Reagents and Equipment Market Breakdown, by Physical/mechanical Method
10.1.1.2.2.2.2 Japan: Transfection Reagents and Equipment Market Breakdown, by Chemical Method
10.1.1.2.3 Japan: Transfection Reagents and Equipment Market Breakdown, by Application
10.1.1.2.4 Japan: Transfection Reagents and Equipment Market Breakdown, by End Users
10.1.1.3 India: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
10.1.1.3.1 India: Transfection Reagents and Equipment Market Breakdown, by Product
10.1.1.3.2 India: Transfection Reagents and Equipment Market Breakdown, by Modality
10.1.1.3.2.1 India: Transfection Reagents and Equipment Market Breakdown, by Viral
10.1.1.3.2.2 India: Transfection Reagents and Equipment Market Breakdown, by Non-Viral
10.1.1.3.2.2.1 India: Transfection Reagents and Equipment Market Breakdown, by Physical/mechanical Method
10.1.1.3.2.2.2 India: Transfection Reagents and Equipment Market Breakdown, by Chemical Method
10.1.1.3.3 India: Transfection Reagents and Equipment Market Breakdown, by Application
10.1.1.3.4 India: Transfection Reagents and Equipment Market Breakdown, by End Users
10.1.1.4 South Korea: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
10.1.1.4.1 South Korea: Transfection Reagents and Equipment Market Breakdown, by Product
10.1.1.4.2 South Korea: Transfection Reagents and Equipment Market Breakdown, by Modality
10.1.1.4.2.1 South Korea: Transfection Reagents and Equipment Market Breakdown, by Viral
10.1.1.4.2.2 South Korea: Transfection Reagents and Equipment Market Breakdown, by Non-Viral
10.1.1.4.2.2.1 South Korea: Transfection Reagents and Equipment Market Breakdown, by Physical/mechanical Method
10.1.1.4.2.2.2 South Korea: Transfection Reagents and Equipment Market Breakdown, by Chemical Method
10.1.1.4.3 South Korea: Transfection Reagents and Equipment Market Breakdown, by Application
10.1.1.4.4 South Korea: Transfection Reagents and Equipment Market Breakdown, by End Users
10.1.1.5 Australia: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
10.1.1.5.1 Australia: Transfection Reagents and Equipment Market Breakdown, by Product
10.1.1.5.2 Australia: Transfection Reagents and Equipment Market Breakdown, by Modality
10.1.1.5.2.1 Australia: Transfection Reagents and Equipment Market Breakdown, by Viral
10.1.1.5.2.2 Australia: Transfection Reagents and Equipment Market Breakdown, by Non-Viral
10.1.1.5.2.2.1 Australia: Transfection Reagents and Equipment Market Breakdown, by Physical/mechanical Method
10.1.1.5.2.2.2 Australia: Transfection Reagents and Equipment Market Breakdown, by Chemical Method
10.1.1.5.3 Australia: Transfection Reagents and Equipment Market Breakdown, by Application
10.1.1.5.4 Australia: Transfection Reagents and Equipment Market Breakdown, by End Users
10.1.1.6 Rest of Asia Pacific: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
10.1.1.6.1 Rest of Asia Pacific: Transfection Reagents and Equipment Market Breakdown, by Product
10.1.1.6.2 Rest of Asia Pacific: Transfection Reagents and Equipment Market Breakdown, by Modality
10.1.1.6.2.1 Rest of Asia Pacific: Transfection Reagents and Equipment Market Breakdown, by Viral
10.1.1.6.2.2 Rest of Asia Pacific: Transfection Reagents and Equipment Market Breakdown, by Non-Viral
10.1.1.6.2.2.1 Rest of Asia Pacific: Transfection Reagents and Equipment Market Breakdown, by Physical/mechanical Method
10.1.1.6.2.2.2 Rest of Asia Pacific: Transfection Reagents and Equipment Market Breakdown, by Chemical Method
10.1.1.6.3 Rest of Asia Pacific: Transfection Reagents and Equipment Market Breakdown, by Application
10.1.1.6.4 Rest of Asia Pacific: Transfection Reagents and Equipment Market Breakdown, by End Users
11. Transfection Reagents and Equipment Market -Industry Landscape
11.1 Overview
11.2 Growth Strategies in The Transfection Reagents and Equipment Market, 2020-2023
11.3 Inorganic Growth Strategies
11.3.1 Overview
11.4 Organic Growth Strategies
11.4.1 Overview
12. Company Profiles
12.1 Thermo Fisher Scientific Inc
12.1.1 Key Facts
12.1.2 Business Description
12.1.3 Products and Services
12.1.4 Financial Overview
12.1.5 SWOT Analysis
12.1.6 Key Developments
12.2 Promega Corp
12.2.1 Key Facts
12.2.2 Business Description
12.2.3 Products and Services
12.2.4 Financial Overview
12.2.5 SWOT Analysis
12.2.6 Key Developments
12.3 F. Hoffmann-La Roche Ltd
12.3.1 Key Facts
12.3.2 Business Description
12.3.3 Products and Services
12.3.4 Financial Overview
12.3.5 SWOT Analysis
12.3.6 Key Developments
12.4 Bio-Rad Laboratories Inc
12.4.1 Key Facts
12.4.2 Business Description
12.4.3 Products and Services
12.4.4 Financial Overview
12.4.5 SWOT Analysis
12.4.6 Key Developments
12.5 Mirus Bio LLC
12.5.1 Key Facts
12.5.2 Business Description
12.5.3 Products and Services
12.5.4 Financial Overview
12.5.5 SWOT Analysis
12.5.6 Key Developments
12.6 QIAGEN NV
12.6.1 Key Facts
12.6.2 Business Description
12.6.3 Products and Services
12.6.4 Financial Overview
12.6.5 SWOT Analysis
12.6.6 Key Developments
12.7 Merck KGaA
12.7.1 Key Facts
12.7.2 Business Description
12.7.3 Products and Services
12.7.4 Financial Overview
12.7.5 SWOT Analysis
12.7.6 Key Developments
12.8 Lonza Group AG
12.8.1 Key Facts
12.8.2 Business Description
12.8.3 Products and Services
12.8.4 Financial Overview
12.8.5 SWOT Analysis
12.8.6 Key Developments
12.9 MaxCyte Inc
12.9.1 Key Facts
12.9.2 Business Description
12.9.3 Products and Services
12.9.4 Financial Overview
12.9.5 SWOT Analysis
12.9.6 Key Developments
13. Appendix
13.1 About Us
List of Tables
Table 1. Asia Pacific Transfection Reagents and Equipment Market Segmentation
Table 2. Asia Pacific Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
Table 3. Asia Pacific Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million) - by Product
Table 4. Asia Pacific Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million) - by Modality
Table 5. Asia Pacific Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million) - by Viral
Table 6. Asia Pacific Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million) - by Non-Viral
Table 7. Asia Pacific Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million) - by Physical/mechanical Method
Table 8. Asia Pacific Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million) - by Chemical Method
Table 9. Asia Pacific Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million) - by Application
Table 10. Asia Pacific Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million) - by End Users
Table 11. Asia Pacific: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Country
Table 12. China: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Product
Table 13. China: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Modality
Table 14. China: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Viral
Table 15. China: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Non-Viral
Table 16. China: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Physical/mechanical Method
Table 17. China: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Chemical Method
Table 18. China: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Application
Table 19. China: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by End Users
Table 20. Japan: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Product
Table 21. Japan: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Modality
Table 22. Japan: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Viral
Table 23. Japan: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Non-Viral
Table 24. Japan: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Physical/mechanical Method
Table 25. Japan: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Chemical Method
Table 26. Japan: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Application
Table 27. Japan: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by End Users
Table 28. India: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Product
Table 29. India: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Modality
Table 30. India: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Viral
Table 31. India: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Non-Viral
Table 32. India: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Physical/mechanical Method
Table 33. India: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Chemical Method
Table 34. India: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Application
Table 35. India: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by End Users
Table 36. South Korea: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Product
Table 37. South Korea: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Modality
Table 38. South Korea: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Viral
Table 39. South Korea: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Non-Viral
Table 40. South Korea: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Physical/mechanical Method
Table 41. South Korea: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Chemical Method
Table 42. South Korea: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Application
Table 43. South Korea: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by End Users
Table 44. Australia: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Product
Table 45. Australia: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Modality
Table 46. Australia: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Viral
Table 47. Australia: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Non-Viral
Table 48. Australia: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Physical/mechanical Method
Table 49. Australia: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Chemical Method
Table 50. Australia: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Application
Table 51. Australia: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by End Users
Table 52. Rest of Asia Pacific: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Product
Table 53. Rest of Asia Pacific: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Modality
Table 54. Rest of Asia Pacific: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Viral
Table 55. Rest of Asia Pacific: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Non-Viral
Table 56. Rest of Asia Pacific: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Physical/mechanical Method
Table 57. Rest of Asia Pacific: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Chemical Method
Table 58. Rest of Asia Pacific: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Application
Table 59. Rest of Asia Pacific: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by End Users
Table 60. Recent Inorganic Growth Strategies in the Transfection Reagents and Equipment Market
Table 61. Recent Organic Growth Strategies in The Transfection Reagents and Equipment Market
List of Figures
Figure 1. Asia Pacific Transfection Reagents and Equipment Market Segmentation, by Country
Figure 2. Impact Analysis of Drivers and Restraints
Figure 3. Asia Pacific Transfection Reagents and Equipment Market Revenue (US$ Million), 2022-2030
Figure 4. Asia Pacific Transfection Reagents and Equipment Market Share (%) - by Product (2022 and 2030)
Figure 5. Reagents: Asia Pacific Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 6. Equipment: Asia Pacific Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 7. Asia Pacific Transfection Reagents and Equipment Market Share (%) - by Modality (2022 and 2030)
Figure 8. Viral: Asia Pacific Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 9. Retrovirus: Asia Pacific Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 10. Adenovirus: Asia Pacific Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 11. Adeno-Associated Virus: Asia Pacific Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 12. Herpes Virus: Asia Pacific Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 13. Non-Viral: Asia Pacific Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 14. Physical/Mechanical: Asia Pacific Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 15. Electroporation: Asia Pacific Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 16. Microinjection: Asia Pacific Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 17. Biolistic Method: Asia Pacific Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 18. Laser Method: Asia Pacific Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 19. Magnetofection: Asia Pacific Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 20. Sonoporation: Asia Pacific Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 21. Chemical Method: Asia Pacific Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 22. Liposomal Based/High Lipid: Asia Pacific Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 23. Non-Liposomal Based/High Lipid: Asia Pacific Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 24. Hybrid: Asia Pacific Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 25. Asia Pacific Transfection Reagents and Equipment Market Share (%) - by Application (2022 and 2030)
Figure 26. Biomedical Research: Asia Pacific Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 27. Protein Production: Asia Pacific Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 28. Therapeutic Delivery: Asia Pacific Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 29. Asia Pacific Transfection Reagents and Equipment Market Share (%) - by End Users (2022 and 2030)
Figure 30. Academic and Research Institutes: Asia Pacific Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 31. Pharmaceutical and Biotechnological Companies: Asia Pacific Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 32. Asia Pacific: Transfection Reagents and Equipment Market- Revenue by Key Countries 2022 (US$ Million)
Figure 33. Asia Pacific: Transfection Reagents and Equipment Market Breakdown, by Key Countries, 2022 and 2030 (%)
Figure 34. China: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million)
Figure 35. Japan: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million)
Figure 36. India: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million)
Figure 37. South Korea: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million)
Figure 38. Australia: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million)
Figure 39. Rest of Asia Pacific: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million)
Figure 40. Growth Strategies in The Transfection Reagents and Equipment Market, 2020-2023
1. Thermo Fisher Scientific Inc
2. Promega Corp
3. F. Hoffmann-La Roche Ltd
4. Bio-Rad Laboratories Inc
5. Mirus Bio LLC
6. QIAGEN NV
7. Merck KGaA
8. Lonza Group AG
9. MaxCyte Inc
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the Asia Pacific transfection reagents and equipment market.
- Highlights key business priorities in order to assist companies to realign their business strategies.
- The key findings and recommendations highlight crucial progressive industry trends in Asia Pacific transfection reagents and equipment market, thereby allowing players across the value chain to develop effective long-term strategies.
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
- Scrutinize in-depth Asia Pacific market trends and outlook coupled with the factors driving the market, as well as those hindering it.
- Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing, and distribution.